Abner Herrman & Brock LLC Edwards Lifesciences Corp Transaction History

Abner Herrman & Brock LLC

  • $829 Million
  • Q3 2024

A detailed history of Abner Herrman & Brock LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Abner Herrman & Brock LLC holds 10,225 shares of EW stock, worth $757,877. This represents 0.08% of its overall portfolio holdings.

Number of Shares
10,225
Previous 11,431 10.55%
Holding current value
$757,877
Previous $1.06 Million 36.08%
% of portfolio
0.08%
Previous 0.13%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 08, 2024
SELL
$59.7 - $93.78 $71,998 - $113,098
-1,206 Reduced 10.55%
10,225 $675,000
Q2 2024

Jul 18, 2024
SELL
$84.3 - $94.31 $64,068 - $71,675
-760 Reduced 6.23%
11,431 $1.06 Million
Q1 2024

Apr 09, 2024
BUY
$72.54 - $95.56 $884,335 - $1.16 Million
12,191 New
12,191 $1.17 Million
Q4 2023

Jan 09, 2024
SELL
$61.71 - $77.76 $1.22 Million - $1.53 Million
-19,737 Reduced 61.81%
12,193 $930,000
Q3 2023

Oct 10, 2023
SELL
$69.28 - $93.38 $486,276 - $655,434
-7,019 Reduced 18.02%
31,930 $2.21 Million
Q2 2023

Jul 05, 2023
BUY
$81.41 - $94.33 $3.17 Million - $3.67 Million
38,949 New
38,949 $3.67 Million
Q1 2023

Apr 13, 2023
SELL
$74.26 - $84.51 $136,267 - $155,075
-1,835 Reduced 4.37%
40,186 $3.33 Million
Q4 2022

Jan 04, 2023
SELL
$68.3 - $87.44 $823,766 - $1.05 Million
-12,061 Reduced 22.3%
42,021 $3.14 Million
Q3 2022

Oct 06, 2022
BUY
$82.37 - $107.29 $65,072 - $84,759
790 Added 1.48%
54,082 $4.47 Million
Q2 2022

Jul 13, 2022
BUY
$86.5 - $128.27 $12,975 - $19,240
150 Added 0.28%
53,292 $5.07 Million
Q1 2022

Apr 07, 2022
BUY
$101.96 - $128.34 $245,213 - $308,657
2,405 Added 4.74%
53,142 $6.26 Million
Q4 2021

Jan 13, 2022
BUY
$106.37 - $130.68 $319,429 - $392,432
3,003 Added 6.29%
50,737 $6.57 Million
Q3 2021

Oct 06, 2021
BUY
$102.91 - $122.75 $143,353 - $170,990
1,393 Added 3.01%
47,734 $5.4 Million
Q2 2021

Jul 09, 2021
BUY
$83.84 - $104.76 $274,995 - $343,612
3,280 Added 7.62%
46,341 $4.8 Million
Q1 2021

Apr 09, 2021
SELL
$78.68 - $90.67 $1.94 Million - $2.23 Million
-24,610 Reduced 36.37%
43,061 $3.6 Million
Q4 2020

Jan 12, 2021
SELL
$71.69 - $91.23 $952,329 - $1.21 Million
-13,284 Reduced 16.41%
67,671 $6.17 Million
Q3 2020

Oct 08, 2020
BUY
$67.19 - $87.44 $1.71 Million - $2.23 Million
25,465 Added 45.89%
80,955 $6.46 Million
Q2 2020

Jul 10, 2020
BUY
$57.54 - $76.95 $2.12 Million - $2.84 Million
36,865 Added 197.93%
55,490 $3.84 Million
Q1 2020

Apr 09, 2020
SELL
$52.41 - $81.0 $28,982 - $44,793
-553 Reduced 2.88%
18,625 $3.51 Million
Q4 2019

Jan 10, 2020
SELL
$71.7 - $82.09 $17,925 - $20,522
-250 Reduced 1.29%
19,178 $4.47 Million
Q3 2019

Oct 11, 2019
BUY
$61.55 - $75.43 $1.2 Million - $1.47 Million
19,428 New
19,428 $4.27 Million

Others Institutions Holding EW

# of Institutions
1,350
Shares Held
456M
Call Options Held
9.76M
Put Options Held
3.92M
View Full List

About Edwards Lifesciences Corp

EW Quotes by TradingView
  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $45.8B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Abner Herrman & Brock LLC Portfolio

Follow Abner Herrman & Brock LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Abner Herrman & Brock LLC, based on Form 13F filings with the SEC.

News

Stay updated on Abner Herrman & Brock LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email